Table of Contents Table of Contents
Previous Page  52 / 158 Next Page
Information
Show Menu
Previous Page 52 / 158 Next Page
Page Background

52

LISI 2016 FINANCIAL REPORT

The amounts given as scope changes are explained by the entry of LISI Medical Remmele into the consolidation scope of the Group on

May 1 2016.

b) Tangible assets held under a finance lease contract

(in €’000)

Land

Buildings

Technical facilities,

equipment and tools

TOTAL

Gross values at December 31, 2015

11,850

28,348 40,198

Other net changes

Acquisitions

13

44

56

Disposals

EXCHANGE rate differences

72

80

152

GROSS VALUES AT DECEMBER 31, 2016

11,935

28,472 40,407

Depreciation at December 31, 2015

4,670

23,085 27,757

Other net changes

4,159

4,159

Depreciation allowance

264

2,480

2,744

Depreciation reversals

EXCHANGE rate differences

11

49

59

DEPRECIATION AT DECEMBER 31, 2016

4,945

29,773 34,720

NET VALUES AT DECEMBER 31, 2016

6,989

(1,301)

5,688

Given their immaterial nature, the minimum future payments in respect of rents and their current value are not broken down by maturity.

c) Operating lease agreements

The main assets required for operations that do not belong to the Group or its subsidiaries are industrial buildings and office space (head office).

Other operating lease agreements mainly relate to office automation equipment.

No significant commercial leases have been signed with company executives or with companies belonging to executives or their families.

The total annual expense is approximately €18 million.

2.5.1.3 Financial assets and liabilities

Financial assets and liabilities recorded on the balance sheet are broken down into the following accounting categories and classes of financial

instruments:

At 12/31/2016

Breakdown by instrument category

FINANCIAL ASSETS AND LIABILITIES RECORDED

ON BALANCE SHEET

(in €’000)

Net value

accounting

Fair

value

Fair

value via

earnings

Assets

available

for sale

Loans and

receivables

Debt at

depreciated

cost

Instruments

derivatives

Non-current financial assets

9,481

9,481

9,481

Other Non-current assets

950

950

950

Trade and other receivables

260,416 260,416

260,416

Cash and cash equivalents

141,719 141,719 141,719

TOTAL FINANCIAL ASSETS

412,566 412,566 141,719

270,847

Non-current borrowings

253,856 253,856

251,800

2,056

Other non-current financial liabilities (excl. PCA)

5,365

5,365

5,365

Current borrowings

106,037 106,037

106,037

Trade and other accounts payable

304,492 304,492

281,066

23,426

TOTAL FINANCIAL LIABILITIES

669,750 669,750

644,268

25,482

CONSOLIDATED FINANCIAL STATEMENTS

3